The pathogenic role of IL-17A in SSc is quite intriguing: on one hand IL-17A promotes secretion of pro-inflammatory cytokines and enhances immune reactions and on the other it decreases fibrotic responses and abrogates fibrosis. Here, IL17A is linked to systemic sclerosis.